Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iSten...
Q2 2026
Jul 29, 2026
Q1 2026
Apr 30, 2026
FY 2025
Feb 23, 2026
Q4 2025
Q3 2025
Oct 31, 2025